Fig. 1.
Study protocol.
CP-1 patient was classified as having a severe clinical disease course at the 38th week (12 weeks after starting standard treatment) and was given enhanced-dose bezafibrate.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.